Dr. Yolanda Diebold obtained her Ph.D in Ocular Cell Biology at the University of Valladolid (UVA) (Valladolid, Spain) in 1997. Her postdoctoral training was first in Ocular Immunology at UVA and then in Dr. Darlene A. Dartt Laboratory, at the Schepens Eye Research Institute-Harvard Medical School (MA, USA), in which she got expertise in animal models of ocular autoimmune diseases. Currently, she leads the Nanomedicine Applied to Inflammatory Ocular Surface Diseases Laboratory, at the Institute of Applied Ophthalmo-Biology (IOBA) of UVA (Spain), and has uninterrupted regional, national and international funding grants since 2000. Dr. Diebold has published over 77 papers in indexed, peer-reviewed specialized journals, book chapters, and has a h-index of 28 (WOS, January 2025). In addition, shed led 4 International Grants and 15 National and Regional Grants. Finally, she serves as Coordinator of the Doctorate Programme in Visual Sciences.